From the filing
PDF page 396
Printed filing page F-50 · Extracted page text
Read the page text
Table of Contents Anthropic, PBC Notes to Consolidated Financial Statements (Continued) The total shares of the Company’s common stock reserved for future issuance, on an as-if converted basis are as follows (in thousands): Series A Series B Series C-1 Series C-2 Series D-1 Series D-2 Series D-3 Series E-1 Series E-2 Series E-3 Series E-4 Series E-5 Series F-1 Series F-2 Series F-3 Series F-4 Series G-1 Series G-2 Series G-3 Series G-4 Series H-1 Series H-2 Series H-3 Series H-4 As of December 31, 2025 2024 As of June 30, 2026 (unaudited) 485,744 874,304 263,972 133,617 350,128 44,438 49,993 — — — — — — — — — — — — — — — — — 485,744 874,304 263,972 133,617 368,311 46,132 52,589 636,101 952,819 126,646 153,429 242,436 922,197 207,399 — — — — — — — — — — 485,744 874,304 263,972 133,617 370,299 46,314 52,873 636,101 952,819 126,646 153,429 242,436 922,197 207,399 — — 905,104 839,288 205,629 33,216 776,379 331,103 — — Shares available under Donation Matching Plan 964,341 964,341 933,698 Stock options and restricted stock units outstanding 1,736,780 2,603,784 2,846,697 Shares available for future issuance Total shares reserved for issuance Equity Compensation Plan 26,547 287,571 569,059 4,929,864 9,321,392 12,908,323 In January 2021, the Board approved the 2021 Stock Plan (the “Plan”). The Plan allows for the award of incentive stock options, non-statutory stock options, restricted stock awards, and RSUs to employees, non- employee directors, and consultants of the Company. As of December 31, 2025 and June 30, 2026 (unaudited), there were 3,112.4 million shares and 3,864.8 million shares, respectively, of common stock reserved for issuance under the Plan, with 287.6 million shares and 569.1 million shares, respectively, available to be issued. Options issued under the Plan generally are exercisable for periods not to exceed ten years and generally vest over either four years with 25% vesting after one year and with the remainder vesting monthly thereafter in equal installments, or over one year with 100% vesting after one year. Effective January 2026 (unaudited), options issued under the Plan generally are exercisable for periods not to exceed 10 years and generally vest over either four years with 12.5% vesting after six months and with the remainder vesting monthly thereafter in equal installments, or over one year with 50% vesting after six months and with the remainder vesting monthly thereafter in equal installments. F-50
Text is provided for reference. Check the original for tables, images, and exact formatting.